Jun Wang

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Jun Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

90 Article
8 Review article
1 Letter

AG1478 Elicits a Novel Anti-Influenza Function via an EGFR-Independent, GBF1-Dependent Pathway
Zhou, X., Zhu, L., Bondy, C., Wang, J., Luo, Q. & Chen, Y., May 1 2022, In: International journal of molecular sciences. 23, 10, 5557.
Research output: Contribution to journal › Article › peer-review

Open Access
Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
Hu, Y., Jo, H., DeGrado, W. F. & Wang, J., May 2022, In: Journal of Medical Virology. 94, 5, p. 2188-2200 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Cytopathic Effect Assay and Plaque Assay to Evaluate in vitro Activity of Antiviral Compounds Against Human Coronaviruses 229E, OC43, and NL63
Hu, Y., Ma, C. & Wang, J., Feb 5 2022, In: Bio-protocol. 12, 3, e00099.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Enterovirus A71 antivirals: Past, present, and future
Wang, J., Hu, Y. & Zheng, M., Apr 2022, In: Acta Pharmaceutica Sinica B. 12, 4, p. 1542-1566 25 p.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Scopus citations
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
Kitamura, N., Sacco, M. D., Ma, C., Hu, Y., Townsend, J. A., Meng, X., Zhang, F., Zhang, X., Ba, M., Szeto, T., Kukuljac, A., Marty, M. T., Schultz, D., Cherry, S., Xiang, Y., Chen, Y. & Wang, J., Feb 24 2022, In: Journal of Medicinal Chemistry. 65, 4, p. 2848-2865 18 p.
Research output: Contribution to journal › Article › peer-review
33 Scopus citations

Drug target validation of the enterovirus D68 2A protease
Wang, J.
Project: Research project
Drug Discovery Targeting the Influenza A Virus M2-S31N Proton Channel
Wang, J.
Project: Research project
Discovery of broad-spectrum influenza antivirals with a high genetic barrier to drug resistance by targeting the viral polymerase
Wang, J.
Project: Research project
High Throughput Screening of Inhibitors Targeting the Enterovirus A71 and D68 2A Proteases
Wang, J.
Project: Research project
Drug Discovery Targeting the Influenza A Virus M2-S31N Proton Channel
Wang, J.
Project: Research project

Jun Wang

Fingerprint

Network

Dive into details

AG1478 Elicits a Novel Anti-Influenza Function via an EGFR-Independent, GBF1-Dependent Pathway

Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell

Cytopathic Effect Assay and Plaque Assay to Evaluate in vitro Activity of Antiviral Compounds Against Human Coronaviruses 229E, OC43, and NL63

Enterovirus A71 antivirals: Past, present, and future

Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors

Drug target validation of the enterovirus D68 2A protease

Drug Discovery Targeting the Influenza A Virus M2-S31N Proton Channel

Discovery of broad-spectrum influenza antivirals with a high genetic barrier to drug resistance by targeting the viral polymerase

High Throughput Screening of Inhibitors Targeting the Enterovirus A71 and D68 2A Proteases

Drug Discovery Targeting the Influenza A Virus M2-S31N Proton Channel

Jun Wang

Fingerprint

Network

Scholarly Works

Grants